Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
03/2005
03/31/2005WO2005029039A2 Non-radioactive inositol phosphate assay for phospholipase c-coupled drug target screening
03/31/2005WO2005029037A2 Selective modulation of tlr gene expression
03/31/2005WO2005029035A2 Methods of screening compositions for g protein-coupled receptor agonist activity
03/31/2005WO2005029034A2 Methods for the identification of inhibitors of amidophosphoribosyltransferase and cutinase transcription factor 1 as antibiotics
03/31/2005WO2005029033A2 Cyanide sensing compounds and uses thereof
03/31/2005WO2005029030A2 Micro scale flow through sorbent plate collection device
03/31/2005WO2005028680A2 Methods, compositions, and kits for the concentration and detection of microorganisms
03/31/2005WO2005028676A2 Method of diagnosing breast cancer
03/31/2005WO2005028675A2 Methods for detecting, diagnosing and treating hepatocellular carcinomas (hcc)
03/31/2005WO2005028669A1 Time-of-addition assay for identifying anti-viral compounds
03/31/2005WO2005028668A1 General method for enrichment and detection of pathogen bacteria
03/31/2005WO2005028667A1 Drug targeting g protein-coupled receptor expressed in human mast cells and method of screening the same
03/31/2005WO2005028666A2 Determining kinase specificity
03/31/2005WO2005028664A2 Modulation of programmed necrosis
03/31/2005WO2005028663A2 Operator independent programmable sample preparation and analysis system
03/31/2005WO2005028662A2 Test strip and method for determining ldl cholesterol concentration from whole blood
03/31/2005WO2005028657A2 Excretable reporter systems
03/31/2005WO2005028640A1 Method for isolating hepatocytes
03/31/2005WO2005028639A2 Environments that maintain function of primary liver cells
03/31/2005WO2005028624A2 Molecular scaffolds for kinase ligand development
03/31/2005WO2005028621A2 Assays with primary cells
03/31/2005WO2005028620A2 Histone modifications as binary switches controlling gene expression
03/31/2005WO2005028619A2 Nanoliter-scale synthesis of arrayed biomaterials and screening thereof
03/31/2005WO2005028613A2 Method for functionally screening agents which can modulate the activity of ubiquitine hydrolases and uses thereof.
03/31/2005WO2005028516A2 Albumin-binding derivatives of therapeutic peptides
03/31/2005WO2005028510A2 Methods, kits, and compositions for the development and use of monoclonal antibodies specific to antigens of low immunogenicity
03/31/2005WO2005028506A2 Crystal structure of fms-like tyrosine kinase
03/31/2005WO2005028503A1 Peptide originating in hepatitis c virus
03/31/2005WO2005028499A2 Peptide that binds to a broadly neutralizing anti-hiv antibody-structure of 4e10 fab fragment complex, uses thereof, compositions therefrom
03/31/2005WO2005028497A2 Receptor binding peptides derived from the sars s protein
03/31/2005WO2005028489A2 Novel adenosine a3 receptor agonists
03/31/2005WO2005028447A1 Benzimidazole derivates: preparation and pharmaceutical applications
03/31/2005WO2005028424A1 Whole cell assay involving cathepsin s
03/31/2005WO2005028096A2 Microfluidics devices and methods for performing cell based assays
03/31/2005WO2005027963A2 METHODS AND COMPOSITIONS FOR THE GENERATION OF A PROTECTIVE IMMUNE RESPONSE AGAINTS SARS-CoV
03/31/2005WO2005027962A1 4’-thionucleosides and oligomeric compounds
03/31/2005WO2005027886A2 Methods of preventing or treating recurrence of myocardial infarction
03/31/2005WO2005027871A2 Method for production of bioresorbable microparticles microparticles thus obtained and use thereof
03/31/2005WO2005027831A2 Modulators of p-selectin glycoprotein ligand 1
03/31/2005WO2005027733A2 Biological markers for diagnosing multiple sclerosis
03/31/2005WO2005027727A2 Use of pin1 inhibitors for treatment of cancer
03/31/2005WO2005027725A2 Determination of ions using ion-sensitive enzymes
03/31/2005WO2005027719A2 Methods and systems for identifying predisposition to the placebo effect
03/31/2005WO2005027715A2 CRYSTALS AND STRUCTURES OF SARS-CoV MAIN PROTEASE
03/31/2005WO2005027714A2 Sensitive and rapid biodetection
03/31/2005WO2005027713A2 Compositions, splice variants and methods relating to colon specific genes and proteins
03/31/2005WO2005027634A1 Apparatus and methods for selecting capacitated spermatozoa and uses thereof
03/31/2005WO2005027628A1 Receptor
03/31/2005WO2005017205A3 Nucleic acid mapping using linear analysis
03/31/2005WO2005014633A8 Fluorescent protein
03/31/2005WO2005014581A3 Lanthanide complexes preparation and uses thereof
03/31/2005WO2005012556A3 Cationic anti-microbial peptides and methods of use thereof
03/31/2005WO2005008297A3 Integrated virtual slide and live microscope system
03/31/2005WO2005007874A3 Sequential generation of multiple chemiluminescent signals on solid supports
03/31/2005WO2005007822A3 Method for assaying protein-protein interaction
03/31/2005WO2005006236A3 System and method for scoring peptide mass fingerprinting
03/31/2005WO2005004883A3 Compound testing method
03/31/2005WO2005003754A8 Computer-controlled automated titration apparatus for optically determining incompatibility of petroleum oils
03/31/2005WO2005003716A3 Surface imprinting: integration of molecular recognition and transduction
03/31/2005WO2005001477A3 Ligand array processing methods that include a low surface tension fluid deposition step and compositions for practicing the same
03/31/2005WO2005001114A3 Screening methods
03/31/2005WO2004113926A3 Diagnosis of pre-eclampsia
03/31/2005WO2004112829A3 Compositions and methods for the diagnosis and treatment of tumors of glial origin
03/31/2005WO2004111636A3 Peptide combos and their uses
03/31/2005WO2004104554A3 Organic analysis module
03/31/2005WO2004104224A3 Markers for lxr activation
03/31/2005WO2004101780A3 Heparanase-derived peptides for vaccination of tumor patients
03/31/2005WO2004101772A3 Neural cells
03/31/2005WO2004092741A3 Mapping discontinuous antibody or aptamer epitopes for protein structure determination and other applications
03/31/2005WO2004092740A3 Methods for identifying therapeutic targets involved in glucose and lipid metabolism
03/31/2005WO2004092394A3 Fluid planar lipid layer-based membrane-anchored ligand system with specific binding pair members and methods of use thereof
03/31/2005WO2004087744A3 Composition and method for nerve regeneration
03/31/2005WO2004084838A3 Identification, quantification, and characterization of t cells and t cell antigens
03/31/2005WO2004083241A3 Btc-interacting proteins and use thereof
03/31/2005WO2004081477A3 Analytical furnace with predictive temperature control
03/31/2005WO2004081181A3 Method for determining susceptibility of tumor to treatment with anti-neoplastic agent
03/31/2005WO2004080597A3 Sample processing tubule
03/31/2005WO2004080579A3 Liquid tissue preparation from histopatologically processed biological samples, tissues and cells
03/31/2005WO2004076677A3 Monoclonal antibody production by ebv transformation of b cells
03/31/2005WO2004075839A3 Methods and compositions for modulating apoptosis
03/31/2005WO2004074813A3 Test cartridge, system for sensing fluid, and methods
03/31/2005WO2004073499A3 Diagnosis of primary open angle glaucoma
03/31/2005WO2004064742A3 Methods and compositions for p2x receptor calcium entry channels and other calcium entry mechanisms
03/31/2005WO2004064711A3 Modulation of deubiquitinase family members
03/31/2005WO2004063712A3 Methods for diagnosis and prognosis of cancer
03/31/2005WO2004063709A8 Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators
03/31/2005WO2004059293A3 Markers for differential diagnosis and methods of use thereof
03/31/2005WO2004051226A3 Monitoring high-risk environments
03/31/2005WO2004048598A3 Molecular nephrotoxicology modeling
03/31/2005WO2004045547A3 Rnai-based sensors, caged interfering rnas, and methods of use thereof
03/31/2005WO2004043371A3 Methods and compositions for modulating p53 transcription factor
03/31/2005WO2004043233A3 Assay for autoantibodies to folate receptors
03/31/2005WO2004041192A3 Panels of molecular targets differentially expressed during cd8+ t-cell priming
03/31/2005WO2004036221A3 Compositions and methods for diagnosing and treating autoimmune disease
03/31/2005WO2004029573A3 Low power gas leak detector
03/31/2005WO2004010108A9 Method for the identification of ligands
03/31/2005WO2003087769A3 Method for identifying modulators of ion channels
03/31/2005WO2003083441A3 Identification of apoptotic peptides and methods of use thereof
03/31/2005WO2003076900A3 Multiplexed analysis of cell-substrate interactions
03/31/2005WO2003066811A3 Msrebps as modifiers of the srebp pathway and methods of use
1 ... 2144 2145 2146 2147 2148 2149 2150 2151 2152 2153 2154 2155 2156 2157 2158 2159 2160 2161 2162 2163 2164 ... 3937